Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations

J Am Acad Dermatol. 1998 Feb;38(2 Pt 2):318-21. doi: 10.1016/s0190-9622(98)70573-0.

Abstract

The potential for a variety of local and systemic side effects from the use of potent topical corticosteroids has long been recognized. However, adrenal suppression has only rarely been documented. We describe two patients with profound hypothalamic-pituitary-adrenal axis suppression resulting from the unregulated use of super potent topical corticosteroids.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Topical
  • Adrenal Glands / drug effects*
  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects*
  • Betamethasone / administration & dosage
  • Betamethasone / adverse effects
  • Betamethasone / analogs & derivatives*
  • Chronic Disease
  • Clobetasol / administration & dosage
  • Clobetasol / adverse effects
  • Clobetasol / analogs & derivatives*
  • Depression, Chemical
  • Female
  • Glucocorticoids
  • Humans
  • Male
  • Ointments
  • Psoriasis / complications
  • Psoriasis / drug therapy
  • Self Medication / adverse effects

Substances

  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Ointments
  • betamethasone-17,21-dipropionate
  • Betamethasone
  • Clobetasol